(Q43035299)

English

Induction of neutralizing antibody responses to hepatitis C virus with synthetic peptide constructs incorporating both antibody and T-helper epitopes

scientific article published on 23 January 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Induction of neutralizing antibody responses to hepatitis C virus with synthetic peptide constructs incorporating both antibody and T-helper epitopes (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

1 reference

based on heuristic

inferred from title

Hepatitis C virus

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Heidi E Drummer

5

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

object named as

David C Jackson

6

0 references

author name string

Alex Fischer

2

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Lara Grollo

3

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Weiguang Zeng

4

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

publication date

23 January 2007

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Immunology & Cell Biology

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

85

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

169-173

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Molecular viral oncology of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100021

21 January 2018

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100021

21 January 2018

Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100021

21 January 2018

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100021

21 January 2018

High resolution analysis of cellular immune responses in resolved and persistent hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100021

21 January 2018

Full-breadth analysis of CD8+ T-cell responses in acute hepatitis C virus infection and early therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100021

21 January 2018

Broad repertoire of the CD4+ Th cell response in spontaneously controlled hepatitis C virus infection includes dominant and highly promiscuous epitopes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100021

21 January 2018

Clearance of hepatitis C viremia associated with cellular immunity in the absence of seroconversion in the hepatitis C incidence and transmission in prisons study cohort

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100021

21 January 2018

In vitro assay for neutralizing antibody to hepatitis C virus: Evidence for broadly conserved neutralization epitopes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100021

21 January 2018

Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100021

21 January 2018

Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100021

21 January 2018

Characterization of the hepatitis C virus E2 epitope defined by the broadly neutralizing monoclonal antibody AP33.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100021

21 January 2018

Neutralizing antibodies to hepatitis C virus (HCV) in immune globulins derived from anti-HCV-positive plasma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100021

21 January 2018

Preclinical Evaluation of Two Neutralizing Human Monoclonal Antibodies against Hepatitis C Virus (HCV): a Potential Treatment To Prevent HCV Reinfection in Liver Transplant Patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100021

21 January 2018

Antibody responses to hepatitis C virus hypervariable region 1: evidence for cross-reactivity and immune-mediated sequence variation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100021

21 January 2018

Hypervariable region 1 of hepatitis C virus: immunological decoy or biologically relevant domain?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100021

21 January 2018

Induction of cross-reactive humoral immune response by immunization with mimotopes of the hypervariable region 1 of the hepatitis C virus.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100021

21 January 2018

Broadly cross-reactive, high-affinity antibody to hypervariable region 1 of the hepatitis C virus in rabbits

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100021

21 January 2018

Cell surface expression of functional hepatitis C virus E1 and E2 glycoproteins

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100021

21 January 2018

Inhibition of hepatitis C virus-like particle binding to target cells by antiviral antibodies in acute and chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100021

21 January 2018

Preparation and properties of totally synthetic immunogens

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100021

21 January 2018

Highly immunogenic and totally synthetic lipopeptides as self-adjuvanting immunocontraceptive vaccines.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100021

21 January 2018

Identification of canine helper T-cell epitopes from the fusion protein of canine distemper virus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100021

21 January 2018

Genetic control and fine specificity of the immune response to a synthetic peptide of influenza virus hemagglutinin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100021

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.ICB.7100021

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43035299&oldid=1978268071"